CompareUltrasightvsEko Health

Ultrasight is an AI cardiology platform for clinicians performing cardiac ultrasound, with real-time guidance for image capture at the point of care.

1. Clinical role: It supports image acquisition and workflow rather than autonomous cardiology, so cardiologist review remains essential for treatment and reporting decisions.
2. Best-fit environment: Clinicians performing cardiac ultrasound benefit when real-time AI scan guidance for echo fits point-of-care workflows.
3. Evaluation priorities: Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, clinical validation evidence, and interpretation requirements before rollout.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, with validation depth, support coverage, and rollout planning important.

Ultrasight is best assessed as real-time echo guidance whose value depends on workflow fit, clinical oversight, and readiness.

Eko Health combines digital stethoscopes with AI to detect heart and lung conditions during exams.

1. Clinical role: It supports cardiac assessment and risk stratification rather than autonomous cardiology, so clinician review remains essential for treatment and reporting decisions.
2. Best-fit environment: Primary care and cardiology clinicians fit best when AI stethoscope signals align with examination and referral pathways.
3. Implementation checks: Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, validation evidence, and clinician review requirements before rollout.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, making implementation scope a purchasing consideration.

Eko Health is best assessed as a focused cardiology support layer whose value depends on clinical oversight, workflow fit, and confirmation of positive findings.